Helaina

In a recent podcast with Nutritional Outlook, our Founder & CEO, Laura Katz shares how Helaina's cutting-edge technology replicates bioactive proteins to match those in the human body. Tune in to learn how effera™ human lactoferrin can power your next innovative product formulation for food, beverage, and dietary supplement applications.

Our gut and immune white paper 🔬 is here, written by Susan Hewlings and Cassandra Evans Carson Lactoferrin (LF) is a glycoprotein found in various body fluids, including milk with its highest concentration in colostrum. Lactoferrin has remarkable iron-binding properties making it a powerhouse for gut and immune health. LF supports both innate and adaptive immunity by activating immune cells, while also promoting intestinal tissue growth, repair, and homeostasis. Additionally, LF supports the growth of beneficial gut bacteria, such as Bifidobacteria. Its benefits make LF an ideal component for functional foods and dietary supplements. effera™, a human lactoferrin equivalent, offers high bioavailability and low allergenic risk positioning it as an exciting novel ingredient for gut and immune support. Find out more by using the link below to download the white paper. https://lnkd.in/eMT7tpbv Douglas Kalman PhD RD

Helaina has been recognized by Business Insider as one of the 85 Most Promising Startups of 2024. The article focuses on what sets businesses apart 🌟 and highlights Helaina's goal to revolutionize nutrition with bioactive proteins and its flagship product, effera™ human lactoferrin. Marisa Bass, Primary Venture Partners highlights Helaina's tremendous strides, A+ team, and impressive commercial traction. The company's potential for breakthrough success in 2024 is truly exciting. Check out the full list of promising startups below and see how Helaina is making waves in the science world. 🌐

Having our lab right here at home in New York City gives us the ability to efficiently develop new ingredients, allowing us to quickly respond to market demands and consumer needs. We love opening our door to the community - check out our time with Seema Kumar, CEO at Cure.

Helaina is excited to share two articles recently published in the renowned Journal Food and Chemical Toxicology. The first, a review publication supports the safety of recombinant human lactoferrin as an ingredient. It demonstrates the absorption, distribution, metabolism and excretion of lactoferrin (human and bovine) is well established. The animal and human safety data on recombinant human lactoferrin also support it is well tolerated without adverse effects on iron parameters. Study Link - https://lnkd.in/e5-zRQwB The second, is a workshop report on the safety study roadmap for effera™. Helaina’s safety plan was put together by scientists at Helaina and vetted by key scientific experts in immunology, toxicology/immunotoxicology, food ingredient risk assessment, and lactoferrin biology to meet GRAS requirement of general recognition. It addresses key safety questions regarding consuming effera™ as a food ingredient in the diet for adults. Study Link - https://lnkd.in/e35rgBDg Helaina is committed to advancing innovation and ensuring the safety of its novel ingredients. These publications highlight our dedication to research, transparency, and safety in product development. Through scientific excellence we support the health and well-being of our consumers and drive innovation for manufacturers.

Tune in today to listen to Laura Katz, CEO of Helaina - a company that has developed a precision fermentation platform to recreate the bioactive proteins found in human colostrum and milk to improve health outcomes. Helaina's innovative approach aims to deliver the health benefits of these nutrients—such as improved immune function and gut health—across all life stages.

Day 2 at Institute of Food Technologists (IFT)! We are thrilled to be exhibiting at the IFT Tradeshow in Chicago this year. Our team is eager to share our cutting-edge solutions that are shaping the future of functional foods and dietary supplements. It's not too late to come and stop by our booth #4474AY in the startup pavilion and learn more about our novel ingredient effera™ human equivalent lactoferrin.

We are just a week away from the Institute of Food Technologists (IFT)Annual Event. Helaina will be showcasing and offering samples of our clinically-studied ingredient, Effera™ Human Lactoferrin. Visit us at booth #4474AY to learn more about Effera's iron-optimizing benefits or click the link below to schedule a meeting. See you in Chicago! https://lnkd.in/eHT2a9cn

Join our dynamic team of professionals. Are you a driven individual with a passion for sales? We are looking for an enthusiastic sales professional to join our growing team at Helaina. At Helaina you will have the opportunity to showcase your sales skills, build relationships with clients, and contribute to our expanding market presence. Ready to take the next step in your sales career? Use the link below to apply.

We are headed to the 2024 IFT. Meet with us at the startup pavilion to learn more about our novel ingredient Effera™ , the first Human Lactoferrin, backed by clinical studies. DM to book a meeting, see you there!